Furthermore, the mutation V684E was found in AML, which lies in the phosphatase domain of SHIP1 and was shown to reduce the catalytic effect of the protein, which in turn raises AKT activity [15]. This evidence concerns the gene AKT1 and acute myeloid leukemia.